(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.38%) $966.30
(-0.36%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
Live Chart Being Loaded With Signals
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services)...
Stats | |
---|---|
Šios dienos apimtis | 16 828.00 |
Vidutinė apimtis | 46 090.00 |
Rinkos kapitalizacija | 159.91M |
EPS | $0 ( 2024-05-02 ) |
Kita pelno data | ( $0.0200 ) 2024-05-16 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 188.00 |
ATR14 | $0.0290 (0.39%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-01 | Lachance Carrie | Buy | 50 000 | Common Stock |
2024-03-01 | Lachance Carrie | Sell | 20 032 | Common Stock |
2024-03-01 | Lachance Carrie | Sell | 50 000 | Restricted Stock Units |
2024-02-09 | Chupa Addam | Buy | 3 000 | Common Stock |
2024-02-09 | Chupa Addam | Sell | 1 374 | Common Stock |
INSIDER POWER |
---|
-9.36 |
Last 99 transactions |
Buy: 1 084 127 | Sell: 1 402 213 |
Tūris Koreliacija
InfuSystem Holdings Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
InfuSystem Holdings Inc Koreliacija - Valiuta/Žaliavos
InfuSystem Holdings Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $125.79M |
Bruto pelnas: | $61.02M (48.51 %) |
EPS: | $0.0415 |
FY | 2023 |
Pajamos: | $125.79M |
Bruto pelnas: | $61.02M (48.51 %) |
EPS: | $0.0415 |
FY | 2022 |
Pajamos: | $109.91M |
Bruto pelnas: | $62.57M (56.93 %) |
EPS: | $0.000900 |
FY | 2021 |
Pajamos: | $102.38M |
Bruto pelnas: | $60.20M (58.80 %) |
EPS: | $0.0690 |
Financial Reports:
No articles found.
InfuSystem Holdings Inc
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.